ACCP Generates 21% Gains in a Week, Spurred by Progress of CobaCyte Platform and Commercial Launch of MuGard

Access Pharmaceuticals Inc. (OTC BB: ACCP) closed October 5 session at $2.37, up 21.5% since the September 30 price of $1.95.  The company’s price was driven by several developments concerning the SiRNA program, particularly related to the rebranding of the targeted-drug delivery technology as CobaCyte and submitting of additional patent applications for its improved formulations. In addition, two weeks ago - Continue Reading »

Lpath Inc. surged 66% over the last month on solid progress of iSONEP trials

Shares of Lpath Inc. (OTC BB: LPTN) reached $0.93 yesterday, up 66% since September 8 low of $0.56. The huge recovery came after the company announced encouraging results from its phase 1 trial with iSONEP and concluded that iSONEP holds potential as a novel therapy for wet AMD and RPE detachment. In addition, the company is soon to announce the - Continue Reading »

Hot OTCBB: FHCO Poised to Alleviate the Negative Effects of Q3 Dip in Revenues

The Female Health Company (Nasdaq: FHCO) stock was traded between $4.75-$5.00 over the last month after it dropped from the May high of $6.64. Due to a delay in two large pending orders, the company reported a 75% dip in revenues for Q3 FY2010, ended June 30, 2010, and a 99% decline in operating incomes. As of September 23, FHCO - Continue Reading »

OTCBB Watch – Why Paid Inc. (PAYD) Soared 23% and Continues to Climb

Paid Inc. (OTCBB: PAYD) stock has been highly volatile over the last three months, trading in the range of $0.19-0.32. On September 22, the company spurred 23% to $0.32 following management’s outlook of strong growth that could make 2010 revenues to exceed those form 2009.  The market traded approximately 2.7 million shares of Paid compared to an average of 0.5 - Continue Reading »

OTCBB Watchlist – Neurologix Phase II Trials Data for its Parkinson’s Disease Therapy

Neurologix Inc. (NRGX.OB) soared 10.32% to $1.39 yesterday on anticipations that more positive data from the phase II trial of the company’s investigational gene therapy for advanced Parkinson’s disease would be released by September 28 at a conference in Glasgow, Scotland. Despite the good news yesterday, shares fell 5.04% to $1.32 mid-day today. Shares of Neurologix have rallied between $1.20-$1.30 - Continue Reading »

Hot OTCBB Stock – China Shuangji Cement Spikes 63% – Shares Rally on Upcoming New Facility Opening

China Shuangji Cement Ltd. (OTCBB: CSGJ) stock price increased 63% since the September 10 low of $0.35 to the September 15 high of $0.57 on positive news concerning imminent opening of a new production facility and strong growth outlook. The daily trading volume increased accordingly from an average of 50,000 shares over the last three months to 425,000 on September - Continue Reading »

OTCBB Stock Watch – Rotech Healthcare (ROHI) Poised for Recovery on Good Initiatives and Medicare Policies

Rotech Healthcare Inc. (ROHI.OB) is recovering from a 450% decline when the company’s stock price dropped from $3.45 on April 23 to $0.76 on July 8.  There were strong expectations that competitive bidding rounds organized by Centers for Medicare & Medicaid Services (CMS) would be delayed as it was a few years ago. The company is currently traded at $1.62 - Continue Reading »

Small-Cap Stock Alert: Augme Technologies up 68% since Beginning of September

Augme Technologies Inc. (AUGT.OB) increased 68% since the beginning of September closing at $2.07 on September 10 on a solid growth story and optimistic management outlook. The company recently announced that it expects to report revenues in excess of $600,000 for its second quarter, which ended August 31, 2010. This represents an incremental increase of more than 100% relative to - Continue Reading »

Viking Systems (VKNG) Soars 61% on Scheduled Product Launch

Viking Systems Inc. (OTC BB: VKNG) stock increased 61% on September 8, after the Company announced that it has received clearance from Food and Drug Administration to start commercialization of its Next Generation 3DHD visualization system. The system is scheduled for market launch in Washington D.C. at 2010’s American College of Surgeons’ Annual Clinical Congress which was planned to be - Continue Reading »

Top Stock Watch: ENER Gains on Lower-than-Expected Losses and Increased Revenue

Energy Conversion Devices Inc. (NASDAQ: ENER) a leader in the design, manufacturing, and sale of photovoltaic (PV) products today reported a wider fourth-quarter loss than in the same quarter one year ago, however in an interesting twist that benefited shareholders the reported loss was less than Wall Street analysts had projected, and the company also beat analysts’ revenue predictions, posting - Continue Reading »